We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

OTC Markets OTCPK - Delayed Quote USD

SIMPLY SOLVENTLESS CONCENTRATES (SSLCF)

0.4500

+0.0320

+(7.66%)

As of 2:06:22 PM EDT. Market Open.

Key Events

Loading Chart for SSLCF

Previous Close 0.4180
Open 0.4500
Bid 0.4400 x --
Ask 0.5188 x --
Day's Range 0.4500 - 0.4500
52 Week Range 0.2476 - 0.6000
Volume 3,000
Avg. Volume 35,460
Market Cap (intraday) 48.714M
Beta (5Y Monthly) -0.46
PE Ratio (TTM) 45.00
EPS (TTM) 0.0100
Earnings Date Apr 28, 2025 - May 2, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada. The company was incorporated in 2020 and is based in Calgary, Canada.

www.simplysolventless.net

--

Full Time Employees

December 31

Fiscal Year Ends

Sector

Drug Manufacturers - Specialty & Generic

Industry

SIMPLY SOLVENTLESS ANNOUNCES THAT PROFITABILITY HAS BEEN ACHIEVED AT HUMBLE GROW CO., THAT INITIAL RESULTS ARE EXCEEDING PROJECTIONS & 2024 ANNUAL FINANCIAL RESULTS WILL BE RELEASED ON APRIL 30, 2025

SIMPLY SOLVENTLESS ANNOUNCES THAT PROFITABILITY HAS BEEN ACHIEVED AT HUMBLE GROW CO., THAT INITIAL RESULTS ARE EXCEEDING PROJECTIONS & 2024 ANNUAL FINANCIAL RESULTS WILL BE RELEASED ON APRIL 30, 2025

SIMPLY SOLVENTLESS PROVIDES Q1 2025 GUIDANCE INCLUDING PROJECTED RECORD ANNUALIZED Q1 REVENUE OF $50.0 MILLION & NORMALIZED NET INCOME OF $12.0 MILLION ($0.10 PER DILUTED SHARE) AND APPOINTS THOMAS FACCIOLO AS VICE PRESIDENT, CONTINUOUS IMPROVEMENT AND PRODUCT DEVELOPMENT

SIMPLY SOLVENTLESS PROVIDES Q1 2025 GUIDANCE INCLUDING PROJECTED RECORD ANNUALIZED Q1 REVENUE OF $50.0 MILLION & NORMALIZED NET INCOME OF $12.0 MILLION ($0.10 PER DILUTED SHARE) AND APPOINTS THOMAS FACCIOLO AS VICE PRESIDENT, CONTINUOUS IMPROVEMENT AND PRODUCT DEVELOPMENT

Is Simply Solventless Concentrates Ltd.'s (CVE:HASH) 8.7% ROE Better Than Average?

Is Simply Solventless Concentrates Ltd.'s (CVE:HASH) 8.7% ROE Better Than Average?

SIMPLY SOLVENTLESS ANNOUNCES HIGHLY ACCRETIVE ALL SHARE DEAL TO ACQUIRE CANADABIS (STIGMA GROW), CREATING #2 CONCENTRATES AND #5 PREROLL PRODUCER, AND CANADABIS ANNOUNCES $2.5 MILLION CONVERTIBLE DEBENTURE FINANCING

SIMPLY SOLVENTLESS ANNOUNCES HIGHLY ACCRETIVE ALL SHARE DEAL TO ACQUIRE CANADABIS (STIGMA GROW), CREATING #2 CONCENTRATES AND #5 PREROLL PRODUCER, AND CANADABIS ANNOUNCES $2.5 MILLION CONVERTIBLE DEBENTURE FINANCING

SIMPLY SOLVENTLESS ANNOUNCES CLOSING OF HIGHLY ACCRETIVE DELTA 9 BIO-TECH ACQUISITION, DELTA 9 BIO-TECH NAME CHANGE TO HUMBLE GROW CO., AND OFFICER APPOINTMENT

SIMPLY SOLVENTLESS ANNOUNCES CLOSING OF HIGHLY ACCRETIVE DELTA 9 BIO-TECH ACQUISITION, DELTA 9 BIO-TECH NAME CHANGE TO HUMBLE GROW CO., AND OFFICER APPOINTMENT

Simply Solventless Ranks 14th on the 2025 TSX Venture 50(TM) List of Top Performing Companies & Provides Update on Delta 9 Bio-Tech Closing Date

Simply Solventless Ranks 14th on the 2025 TSX Venture 50(TM) List of Top Performing Companies & Provides Update on Delta 9 Bio-Tech Closing Date

SIMPLY SOLVENTLESS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING FOR GROSS PROCEEDS OF $6.0 MILLION & PROVIDES UPDATE ON CLOSING OF DELTA 9 BIO-TECH ACQUISITION

SIMPLY SOLVENTLESS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING FOR GROSS PROCEEDS OF $6.0 MILLION & PROVIDES UPDATE ON CLOSING OF DELTA 9 BIO-TECH ACQUISITION

SIMPLY SOLVENTLESS ANNOUNCES OVER SUBSCRIPTION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING TO $6.0 MILLION & EXPECTED DELTA 9 BIO-TECH CLOSING DATE OF FEBRUARY 7, 2025

SIMPLY SOLVENTLESS ANNOUNCES OVER SUBSCRIPTION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING TO $6.0 MILLION & EXPECTED DELTA 9 BIO-TECH CLOSING DATE OF FEBRUARY 7, 2025

SIMPLY SOLVENTLESS ANNOUNCES $5.0 MILLION CONVERTIBLE DEBENTURE FINANCING WITH $3.0 MILLION LEAD ORDER, JANUARY RECORD REVENUE & NEAR-TERM PRODUCT LAUNCHES

SIMPLY SOLVENTLESS ANNOUNCES $5.0 MILLION CONVERTIBLE DEBENTURE FINANCING WITH $3.0 MILLION LEAD ORDER, JANUARY RECORD REVENUE & NEAR-TERM PRODUCT LAUNCHES

SIMPLY SOLVENTLESS ANNOUNCES STRATEGIC ACQUISITION OF CANNABIS CULTIVATOR DELTA 9 BIO-TECH, ADDING APPROXIMATELY $12 MILLION ANNUAL REVENUE (25% INCREASE) AND $2.5 MILLION ANNUAL ADJUSTED EBITDA (23% INCREASE), FOR CONSIDERATION OF NIL NET OF EXPECTED WORKING CAPITAL RECEIVED, ANNOUNCES EXECUTIVE APPOINTMENTS, AND PROVIDES $0.40 WARRANTS UPDATE

SIMPLY SOLVENTLESS ANNOUNCES STRATEGIC ACQUISITION OF CANNABIS CULTIVATOR DELTA 9 BIO-TECH, ADDING APPROXIMATELY $12 MILLION ANNUAL REVENUE (25% INCREASE) AND $2.5 MILLION ANNUAL ADJUSTED EBITDA (23% INCREASE), FOR CONSIDERATION OF NIL NET OF EXPECTED WORKING CAPITAL RECEIVED, ANNOUNCES EXECUTIVE APPOINTMENTS, AND PROVIDES $0.40 WARRANTS UPDATE

/C O R R E C T I O N from source -- Simply Solventless Concentrates Ltd./

/C O R R E C T I O N from source -- Simply Solventless Concentrates Ltd./

Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

SSLCF

10.02%

S&P/TSX Composite index (^GSPTSE)

1.17%

1-Year Return

SSLCF

10.00%

S&P/TSX Composite index (^GSPTSE)

11.25%

3-Year Return

SSLCF

10.00%

S&P/TSX Composite index (^GSPTSE)

14.85%

5-Year Return

SSLCF

10.00%

S&P/TSX Composite index (^GSPTSE)

70.29%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

SIMPLY SOLVENTLESS CONCENTRATES

0.4500

+7.66%

Mkt Cap 48.714M

Industry Drug Manufacturers—Specialty & Generic

CanadaBis Capital Inc.

0.0658

+0.46%

Mkt Cap 9.097M

Industry Drug Manufacturers—Specialty & Generic

Adastra Holdings Ltd.

0.0378

0.00%

Mkt Cap 1.353M

Industry Drug Manufacturers—Specialty & Generic

Global Health Clinics Ltd.

0.0100

0.00%

Mkt Cap CAD 93,921

Industry Drug Manufacturers—Specialty & Generic

CanaQuest Medical Corp.

0.0188

0.00%

Mkt Cap 398,774

Industry Drug Manufacturers—Specialty & Generic

Lee's Pharmaceutical Holdings Limited

0.1882

0.00%

Mkt Cap 110.819M

Industry Drug Manufacturers—Specialty & Generic

Bakhu Holdings, Corp.

0.0150

0.00%

Mkt Cap 4.52M

Industry Drug Manufacturers—Specialty & Generic

Parnell Pharmaceuticals Holdings Ltd

0.0800

0.00%

Mkt Cap 1.684M

Industry Drug Manufacturers—Specialty & Generic

Vibe Growth Corporation

0.0500

0.00%

Mkt Cap 539,850

Industry Drug Manufacturers—Specialty & Generic

Maven Brands Inc.

0.0200

0.00%

Mkt Cap CAD 702,818

Industry Drug Manufacturers—Specialty & Generic

RAMM Pharma Corp.

0.0150

0.00%

Mkt Cap CAD 1.791M

Industry Drug Manufacturers—Specialty & Generic

Valuation Measures

    Annual 

As of 4/21/2025

Market Cap

43.61M
Enterprise Value

45.96M
Trailing P/E

38.52
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

3.85
Price/Book (mrq)

4.65
Enterprise Value/Revenue

5.56
Enterprise Value/EBITDA

29.06

Financial Highlights

Profitability and Income Statement

Profit Margin

10.01%
Return on Assets (ttm)

8.37%
Return on Equity (ttm)

14.68%
Revenue (ttm)

11.46M
Net Income Avi to Common (ttm)

1.15M
Diluted EPS (ttm)

0.0100

Balance Sheet and Cash Flow

Total Cash (mrq)

532.48k
Total Debt/Equity (mrq)

28.71%
Levered Free Cash Flow (ttm)

-8.57M

HASH.V SIMPLY SOLVENTLESS CONCENTRATES

0.6100

+8.93%

SBBCF Simply Better Brands Corp.

0.6400

-1.54%

ADFJF ADF Group Inc.

4.1800

0.00%

NYWKF NTG Clarity Networks Inc.

1.1400

-5.79%

TMGEF Thermal Energy International Inc.

0.0800

0.00%

GRUSF Grown Rogue International Inc.

0.3730

+2.19%

ZMDTF Zoomd Technologies Ltd.

0.3400

+9.68%

ROMJF Rubicon Organics Inc.

0.3430

+2.33%

ZTSTF ZTEST Electronics Inc.

0.1600

-13.04%

BIRMF BioRem Inc.

1.4000

0.00%

LOVFF Cannara Biotech Inc.

0.9930

+3.22%

CANOF California Nanotechnologies Corp.

0.4199

-0.05%

DBCCF Decibel Cannabis Company Inc.

0.0429

0.00%

BEWFF BeWhere Holdings Inc.

0.4500

-4.26%

URLOF NameSilo Technologies Corp.

0.7000

+2.20%

BIOYF BioSyent Inc.

7.41

-3.39%